Augmented antinociception following 7-nitro indazole and flurbiprofen in the conscious mouse

Co-administration of the nitric oxide synthase inhibitor, 7-nitro indazole (1 mg/kg i.[.), with the cyclooxygenase inhibitor, flurbiprofen (5–75 mg/kg i.p.), resulted in significantly enhanced antinociceptive activity in mice (formalin-induced hindpaw licking assay) without affecting hindpaw inflamm...

Full description

Saved in:
Bibliographic Details
Published inEuropean journal of pharmacology Vol. 271; no. 2; pp. 445 - 452
Main Authors Gaffen, Zoe, Bland-Ward, Philip A., Pitcher, Anne, Wallace, Pat, Moore, Philip K.
Format Journal Article
LanguageEnglish
Published Amsterdam Elsevier B.V 27.12.1994
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Co-administration of the nitric oxide synthase inhibitor, 7-nitro indazole (1 mg/kg i.[.), with the cyclooxygenase inhibitor, flurbiprofen (5–75 mg/kg i.p.), resulted in significantly enhanced antinociceptive activity in mice (formalin-induced hindpaw licking assay) without affecting hindpaw inflammation. No antinociception was observed in animals pretreated with 7-nitro indazole (1 mg/kg i.p.) and flurbiprofen (100 μg subplantar). Flurbiprofen (50 mg/kg i.p.) pretreatment did not influence the inhibition of cerebellar or spinal cord nitric oxide synthase activity observed after 7-nitro indazole (1 or 25 mg/kg i.p.) administration and did not alter blood pressure in anaesthetised animals. Thus, flurbiprofen acts by a mechanism unrelated to a local anti-inflammatory effect in the hindpaw. Since nitric oxide synthase inhibitors are antinociceptive by an effect in the spinal cord (dorsal horn) this would appear to be a likely location for the nitric oxide synthase and cyclooxygenase enzymes targetted by 7-nitro indazole and flurbiprofen respectively.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ISSN:0014-2999
1879-0712
DOI:10.1016/0014-2999(94)90805-2